MCM
CDLX icon

MAI Capital Management’s Cardlytics CDLX Stock Holding History

MAI Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$200 – 4377
2025
Q3 		$200 Hold
8
– – ﹤0.01% 3713
2025
Q2 		$135 Sell
8
-1
-11% -$17 ﹤0.01% 3884
2025
Q1 		$170 Hold
9
– – ﹤0.01% 3329
2024
Q4 		$346 Buy
+9
New +$344 ﹤0.01% 3328

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MAI Capital Management's CDLX Position: Q4 2025 in Review

MAI Capital Management sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 8 shares — an estimated $200 sold.

MAI Capital Management first reported a position in CDLX in Q4 2024 and held it in 4 quarters. The position peaked at $346 in Q4 2024. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • MAI Capital Management reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • MAI Capital Management sold 8 Cardlytics shares in Q4 2025, an estimated $200.
  • MAI Capital Management first reported a position in Cardlytics in Q4 2024 and held it in 4 quarters.
  • MAI Capital Management's Cardlytics position peaked at $346 in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on MAI Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.